Helsinn Tells Justices Teva 'Badly Misconstrues' On-Sale Bar
Helsinn on Thursday filed its final brief ahead of oral arguments next month in a U.S. Supreme Court case over the on-sale bar in patent cases, arguing that Teva's interpretation "badly...To view the full article, register now.
Already a subscriber? Click here to view full article